RGNT Regentis Biomaterials Ltd.

AMEX · US · Healthcare · Medical Instruments & Supplies · regentis.co.il

1.630USD-1.21%Mkt Cap: 11.45M $P/E: —1d ago

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacryla…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$146.44BUSDP/E 47.5

EssilorLuxottica Société anonyme

$73.12BUSDP/E 27.4

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$25.79BUSDP/E 46.9

DIM

Sartorius Stedim Biotech S.A.

$23.14BUSDP/E 72.7

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.50BUSDP/E 73.0

SOLV

Solventum Corporation

$14.62BUSDP/E 10.5

BAX

Baxter International Inc.

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap11.45M USD

Enterprise Value2.67M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-13.65M USD

Revenue/Share—

Last Price1.630 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees—

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B1.80

EPS (TTM)-2.43

EPS (Forward)—

52W Range

1.2323% of range15.50

52W High15.50 USD

52W Low1.232 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-287.69%

ROA-179.15%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.38M USD

CapEx (TTM)—

FCF Margin—

FCF Yield18.68%

Net Debt-8.92M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.25

Current Ratio5.62

Quick Ratio5.42

Book Value/Sh0.92 USD

Cash/Share1.27 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)10.00 USD

Upside (mean)+513.5%

Target Range10.00 USD – 10.00 USD

# Analysts1

Ownership

Shares Out.7.02M

Float4.26M

Insiders14.04%

Institutions25.19%

Short Interest

Short Ratio0.1d

Short % Float0.13%

Short % Out.0.09%

Shares Short6.61K

Short (prev mo.)8.19K

Technical

SMA 501.954 (-16.6%)

SMA 2003.410 (-52.2%)

Beta—

S&P 52W Chg16.45%

Avg Vol (30d)45.08K

Avg Vol (10d)33.44K

Technical Indicators

RSI (14)35.3

MACD-0.0903

MACD Signal-0.0632

MACD Hist.-0.0271

BB Upper2.187 USD

BB Middle1.876 USD

BB Lower1.565 USD

BB Width33.13%

ATR (14)0.1492 USD

Vol Ratio (20d)0.26x